Rxsight Company Insiders
RXST Stock | USD 46.38 1.55 3.46% |
Slightly above 95 percent of Rxsight's insiders are activelly selling. The analysis of insiders' sentiment of trading Rxsight stock suggests that a very large number of insiders are panicking at this time. Rxsight employs about 374 people. The company is managed by 13 executives with a total tenure of roughly 873 years, averaging almost 67.0 years of service per executive, having 28.77 employees per reported executive.
Rxsight's Insider Buying Vs Selling
5
Selling | Buying |
Latest Trades
2024-11-18 | Ilya Goldshleger | Disposed 3100 @ 45 | View | ||
2024-11-15 | Ilya Goldshleger | Disposed 4875 @ 46 | View | ||
2024-11-12 | Jesse Anderson Corley | Acquired 11111 @ 45.37 | View | ||
2024-10-30 | Ilya Goldshleger | Disposed 3105 @ 51.91 | View | ||
2024-10-28 | Ilya Goldshleger | Disposed 3100 @ 50.64 | View | ||
2024-10-25 | Ilya Goldshleger | Disposed 3100 @ 49.79 | View | ||
2024-10-22 | Ilya Goldshleger | Disposed 3100 @ 49.68 | View | ||
2024-10-18 | Ilya Goldshleger | Disposed 3105 @ 50.09 | View | ||
2024-10-16 | Ilya Goldshleger | Disposed 3100 @ 49.78 | View | ||
2024-10-14 | Ilya Goldshleger | Disposed 3100 @ 50.09 | View | ||
2024-10-11 | Ilya Goldshleger | Disposed 3100 @ 50.19 | View | ||
2024-10-08 | Ilya Goldshleger | Disposed 3100 @ 48.26 | View | ||
2024-10-04 | Ilya Goldshleger | Disposed 3100 @ 48.01 | View | ||
2024-09-30 | Ilya Goldshleger | Disposed 3100 @ 49.02 | View | ||
2024-09-26 | Ilya Goldshleger | Disposed 3105 @ 49.29 | View | ||
2024-09-23 | Ilya Goldshleger | Disposed 3100 @ 52.67 | View | ||
2024-09-20 | Ilya Goldshleger | Disposed 3100 @ 53.19 | View | ||
2024-08-05 | Ilya Goldshleger | Disposed 9000 @ 39.25 | View | ||
2024-07-01 | Shelley B Thunen | Disposed 10000 @ 58.61 | View |
Monitoring Rxsight's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Rxsight |
Rxsight Management Team Effectiveness
The company has return on total asset (ROA) of (0.0992) % which means that it has lost $0.0992 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1399) %, meaning that it created substantial loss on money invested by shareholders. Rxsight's management efficiency ratios could be used to measure how well Rxsight manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.25 in 2024. Return On Capital Employed is likely to drop to -0.33 in 2024. Change To Liabilities is likely to gain to about 6.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 15.2 M in 2024.Common Stock Shares Outstanding is likely to drop to about 31.8 M in 2024. Net Loss is likely to gain to about (57.1 M) in 2024
Rxsight Workforce Comparison
Rxsight is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 8,151. Rxsight holds roughly 374 in number of employees claiming about 5% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.24) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.26) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.26. Rxsight Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rxsight insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rxsight's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Rxsight insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.4186 | 18 | 43 | 77,796 | 129,240 |
2024-09-01 | 0.4286 | 12 | 28 | 212,360 | 108,367 |
2024-06-01 | 0.8667 | 13 | 15 | 60,450 | 120,396 |
2024-03-01 | 0.4211 | 24 | 57 | 633,233 | 526,216 |
2023-12-01 | 0.2963 | 8 | 27 | 91,010 | 1,717,537 |
2023-09-01 | 0.7273 | 8 | 11 | 166,323 | 1,570,634 |
2023-06-01 | 4.0 | 12 | 3 | 179,159 | 1,022,840 |
2022-12-01 | 1.0 | 1 | 1 | 107,236 | 316,694 |
2022-09-01 | 1.0 | 1 | 1 | 107,236 | 316,694 |
2022-06-01 | 4.5 | 9 | 2 | 315,189 | 750,000 |
2022-03-01 | 3.0 | 3 | 1 | 273,154 | 375,000 |
2021-09-01 | 1.0 | 40 | 40 | 10,601,347 | 10,828,725 |
Rxsight Notable Stakeholders
A Rxsight stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Rxsight often face trade-offs trying to please all of them. Rxsight's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Rxsight's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ronald MD | CEO President | Profile | |
Ilya Goldshleger | CoPresident Officer | Profile | |
Eric Weinberg | CoPresident Officer | Profile | |
Shelley Thunen | CoPresident Officer | Profile | |
Matt Haller | Chief Officer | Profile | |
Alex Huang | Investor Relations | Profile | |
Oliver Moravcevic | Vice Relations | Profile | |
Scott Gaines | Senior Process | Profile | |
Caroline Vaughn | Vice Resources | Profile | |
Steve Everly | Senior America | Profile | |
Rebecca Williston | Vice Finance | Profile | |
Roy Freeman | Senior Relations | Profile | |
Maureen OConnell | Senior Affairs | Profile |
About Rxsight Management Performance
The success or failure of an entity such as Rxsight often depends on how effective the management is. Rxsight management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Rxsight management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Rxsight management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.27) | (0.25) | |
Return On Capital Employed | (0.31) | (0.33) | |
Return On Assets | (0.27) | (0.25) | |
Return On Equity | (0.30) | (0.32) |
Please note, the imprecision that can be found in Rxsight's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Rxsight. Check Rxsight's Beneish M Score to see the likelihood of Rxsight's management manipulating its earnings.
Rxsight Workforce Analysis
Traditionally, organizations such as Rxsight use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Rxsight within its industry.Rxsight Manpower Efficiency
Return on Rxsight Manpower
Revenue Per Employee | 238.2K | |
Revenue Per Executive | 6.9M | |
Net Loss Per Employee | 130K | |
Net Loss Per Executive | 3.7M | |
Working Capital Per Employee | 394.4K | |
Working Capital Per Executive | 11.3M |
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.